March 12, 2024 – You are invited to attend Falcons’ Fortunes, FACIT’s premier event to celebrate and grow the entrepreneurial spirit within the cancer research and innovation communities. Now in its 11th year, the Falcons’ Fortunes event features six Ontario rising stars pitching their breakthrough cancer innovation as they compete for the $100,000 Ernsting Entrepreneurship Award.
Category: Announcement
Falcons’ Fortunes 2024 – Pitch Your Cancer Innovation
January 31, 2024 – Apply Now! FACIT invites entrepreneurs and scientists to pitch their Ontario-made cancer innovation to a panel of judges and in front of a live audience for a chance to win the $100,000 award. Falcons’ Fortunes is FACIT’s premier event to celebrate and grow the entrepreneurial spirit within the cancer research community to drive a culture of commercialization where Ontario-based cancer research discoveries becomes Ontario-made solutions to benefit patients worldwide.
Looking ahead to 2024
January 9, 2024 – The FACIT team is delighted to welcome the new year! For 2024, we maintain our focus on commercializing cancer research and attracting high tech jobs to Ontario. We look forward to working together with our stakeholders and partners to create good-paying jobs, accelerate commercialization and encourage the adoption of Ontario’s innovations to improve health care and grow the economy.
Happy Holidays from FACIT
FACIT applauds quizartinib approval: a success for leukemia patients and Canadian cancer research translation
July 24, 2023 – The U.S. FDA announced the approval of quizartinib, an important new therapy for patients with leukemia. This global effort to impact patients in need is to be celebrated while recognizing the contributions from across the Canadian health R&D ecosystem to reach this significant milestone that will now make a difference for patients.
FACIT founded Turnstone Biologics debuts on Nasdaq market
